Incyte Corporation
Incyte Corporation is named on 1 US grants and 70 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 1
- Published applications
- 70
- Inventors
- 133
- Granted in 2026 so far
- 0
- Most recent grant
- 18 Aug 2009
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 29 |
| 2006 | 0 | 11 |
| 2007 | 0 | 10 |
| 2008 | 0 | 7 |
| 2009 | 1 | 3 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 4 |
By publication year.
Technology areas
Share of 71 documents
- C07KPeptides48
- A61KMedicines and medical preparations47
- A61PTherapeutic uses of medicines45
- C12NMicroorganisms or enzymes22
- G01NInvestigating or analysing materials by determining their chemical or physical properties17
- A01KAnimal husbandry12
- C07DHeterocyclic compounds10
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms10
- C07HSugars6
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3
Recent patents
- Polynucleotides encoding signal peptide-containing molecules19 Sep 2013US 2013/0244927 A1
- Methods of using chemokine panec-1 antibodies29 Aug 2013US 2013/0224769 A1
- Polynucleotides Encoding Human Signal Peptide-Containing Proteins25 Jul 2013US 2013/0190250 A1
- Human beta-adrenergic receptor kinase polypeptide and methods7 Mar 2013US 2013/0058942 A1
- Human transmembrane proteins25 Oct 2012US 2012/0270809 A1
Most cited
By later US patents